OSIR

Osiris Therapeutics, Inc. News Headlines

$13.49
*  
0.02
0.15%
Get OSIR Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
SA PRO: Top Long And Short Ideas, Friday March 7
3/8/2014 7:30:00 AM - Seeking Alpha


Osiris Misses on Q4 Earnings - Analyst Blog
3/6/2014 9:10:01 AM - Zacks.com


Pre-Market Earnings Report for March 5, 2014 : BF/B, PETM, NAV, CSIQ, INXN, MEMP, THRM, TRK, FSS, HOV, OSIR, SBLK
3/4/2014 4:00:02 PM - NASDAQ.com News


Athersys: Two Crucial Near-Term Events
2/19/2014 11:56:00 AM - Seeking Alpha


Could PCT Be NeoStem's Breakout Star?
1/27/2014 12:06:00 PM - Seeking Alpha


Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/27/2014 7:00:01 AM - Zacks.com


Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
1/22/2014 2:00:00 PM - Seeking Alpha


Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha


Idenix Pharmaceuticals (IDIX) Soars: Stock Adds 18.2% in Session - Tale of the Tape
12/26/2013 9:11:01 AM - Zacks.com


Zacks #1 Rank Additions for Wednesday - Tale of the Tape
11/27/2013 9:07:10 AM - Zacks.com


Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 6.2% - Tale of the Tape
11/22/2013 9:06:48 AM - Zacks.com


Medivation Q3 Loss Narrower Than Expected - Analyst Blog
11/13/2013 9:06:20 AM - Zacks.com


AstraZeneca to Invest in New Zoladex Facility - Analyst Blog
11/12/2013 12:05:43 PM - Zacks.com


AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog
11/12/2013 9:05:12 AM - Zacks.com


Jazz Pharma Upgraded to Strong Buy - Analyst Blog
11/11/2013 5:00:01 PM - Zacks.com


Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog
11/11/2013 10:00:01 AM - Zacks.com


Osiris Up on Q3 Earnings - Analyst Blog
11/5/2013 9:00:01 AM - Zacks.com


Mid-Afternoon Market Update: JC Penney Falls on Massive Volume Following Imperial Capital Price Target
10/21/2013 2:29:38 PM - Benzinga


Mid-Day Market Update: Hasbro Surges On Upbeat Earnings; Gannett Shares Tumble
10/21/2013 11:51:57 AM - Benzinga


Mid-Morning Market Update: Markets Mixed; McDonald's Posts Higher Q3 Profit
10/21/2013 9:26:03 AM - Benzinga


Mesoblast: Prochymal Deal Controversy Creates Buying Opportunity
10/15/2013 10:52:00 AM - Seeking Alpha


Osiris Shares Continue to Gain - Analyst Blog
10/15/2013 10:30:01 AM - Zacks.com


Pluristem's Promising GvHD Indication Pits It Against Osiris
10/7/2013 5:52:00 PM - Seeking Alpha


Sector Update: Biotech Stocks Helping The NASDAQ
10/2/2013 1:37:11 PM - MT Newswires


Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent
9/12/2013 8:20:00 AM - Seeking Alpha